Migdal Insurance & Financial Holdings’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-500	Closed	-$3K	–	625
2022 Q1	$3K	Sell	500 -1,711	-77%	-$10.3K	﹤0.01%	585
2021 Q4	$21K	Sell	2,211 -1,209	-35%	-$11.5K	﹤0.01%	556
2021 Q3	$37K	Buy	+3,420	New	+$37K	﹤0.01%	492